Join Dr. Jennifer Caudle as she welcomes Dr. Adrian Dobs and Dr. Faysal Yafi to discuss testosterone replacement therapy and an oral softgel option for appropriate hypogonadal men. Topics in this program include safety results from inTUne, the Phase 3, randomized, open-label study of JATENZO, the first and only FDA-approved oral softgel for testosterone replacement therapy. Please see Important Safety Information and Prescribing Information, including BOXED WARNING on increases in blood pressure.